There is growing urgency to find factors to slow cognitive decline, which are the earliest signs of Alzheimer’s and other forms of dementia. The goal of Dr. Yau’s research is to discover the connections between early vascular risk and white matter injury. By identifying biomarkers in the white matter, Dr. Yau hopes to connect these indicators to higher vascular risk in order to slow the rate of cognitive decline and promote healthier brain aging.
This research is funded by the McKnight Brain Research Foundation through the American Brain Foundation and the American Academy of Neurology. Dr. Yau will conduct her research through Massachusetts General Hospital.